← All Companies
Clene Inc.
CLNN · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary Overview We are a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN ) therapeutics. CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystal form, possess unusually high, unique catalytic activities not present in those same elements in bulk form. These catalytic activities drive, support, and maintain beneficial metabolic and energetic cellular reactions within ...
Next Earnings Q2 FY2026 — expected 2026-09-11
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention CLNN discussed_in_filing Cybersecurity topic_mention CLNN discussed_in_filing Trusted Computing topic_mention CLNN discussed_in_filing Blockchain & Crypto topic_mention CLNN discussed_in_filing Regulation topic_mention CLNN discussed_in_filing Cybersecurity topic_mention CLNN discussed_in_filing Trusted Computing topic_mention CLNN discussed_in_filing Blockchain & Crypto topic_mention CLNN discussed_in_filing Regulation topic_mention CLNN discussed_in_filing Cybersecurity topic_mention CLNN discussed_in_filing Trusted Computing topic_mention CLNN discussed_in_filing Blockchain & Crypto topic_mention CLNN discussed_in_filing Regulation topic_mention CLNN discussed_in_filing Healthcare & Bio topic_mention CLNN discussed_in_filing Cybersecurity topic_mention CLNN discussed_in_filing Trusted Computing topic_mention CLNN discussed_in_filing Blockchain & Crypto topic_mention CLNN discussed_in_filing Regulation topic_mention CLNN discussed_in_filing Healthcare & Bio
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-03-17 2025-12-31 0001437749-26-008502 EDGAR 109K words 2025-03-24 2024-12-31 0001437749-25-008956 EDGAR — 2024-03-13 2023-12-31 0001437749-24-007542 EDGAR — 2023-03-13 2022-12-31 0001437749-23-006264 EDGAR — 2022-03-11 2021-12-31 0000950170-22-003410 EDGAR — 2021-03-29 2020-12-31 0001213900-21-018061 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-13 2025-09-30 0001437749-25-034613 EDGAR 39K words 2025-08-14 2025-06-30 0001437749-25-026679 EDGAR — 2025-05-07 2025-03-31 0001437749-25-014918 EDGAR — 2024-11-13 2024-09-30 0001437749-24-034663 EDGAR — 2024-08-07 2024-06-30 0001437749-24-025014 EDGAR — 2024-05-08 2024-03-31 0001437749-24-015209 EDGAR — 2023-11-07 2023-09-30 0001437749-23-030487 EDGAR — 2023-08-14 2023-06-30 0001437749-23-023409 EDGAR — 2023-05-12 2023-03-31 0001437749-23-014242 EDGAR — 2022-11-07 2022-09-30 0000950170-22-022333 EDGAR — 2022-08-15 2022-06-30 0000950170-22-017214 EDGAR — 2022-05-09 2022-03-31 0000950170-22-008241 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-17 0001437749-26-008482 EDGAR 4K words 2026-03-12 0001437749-26-007828 EDGAR — 2026-02-24 0001437749-26-005156 EDGAR — 2026-01-13 0001437749-26-001196 EDGAR — 2026-01-12 0001437749-26-001049 EDGAR — 2025-12-03 0001437749-25-036713 EDGAR — 2025-12-03 0001437749-25-036712 EDGAR — 2025-11-13 0001437749-25-034621 EDGAR — 2025-10-17 0001437749-25-031277 EDGAR — 2025-10-14 0001437749-25-030891 EDGAR —
176 total filings indexed. 148 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001822791
Ticker CLNN
Exchange Nasdaq
SIC 2834: Pharmaceutical Preparations
Incorporated DE
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 5ca9179c2e3ec76a87eaa9573788deec7488725421bccb09210adee152988815
parent: 1b416b0077c4b0d5f8b44af4d889187b66ef904cd3229ae994df75d47c196e16
content hash: 2cd230149f8b57208b5d3094d34c42a27c1002525b4e177579b0ef88b76169b6
signed: 2026-04-13T04:44:21.752Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf